This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J. Z.
Right arrow Articles by Levy, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J. Z.
Right arrow Articles by Levy, J. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2003, p. 3321-3322, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3321-3322.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Virucidal Efficacy of Soap and Water against Human Immunodeficiency Virus in Genital Secretions

Jonathan Z. Li, Elizabeth C. Mack, and Jay A. Levy*

Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California

Received 10 April 2003/ Returned for modification 18 June 2003/ Accepted 22 July 2003


arrow
ABSTRACT
 
A common bar soap and tap water solution was able to demonstrate a 30-fold human immunodeficiency virus (HIV) inactivation and a 57 to 87% reduction in viable peripheral blood mononuclear cells in a mixture of cervicovaginal lavage fluid and seminal fluid. These observations indicate that soap and water might be used to inactivate HIV and HIV-infected cells in genital secretions.


arrow
TEXT
 
Postcoital genital cleansing with soap and water may be effective in preventing human immunodeficiency virus (HIV) infection (9), but the direct effect of a soap solution on HIV has not been reported. HIV can be inactivated by a variety of chemicals and surfactants (6, 7) as well as by an antimicrobial hand wash product (3). However, these agents may be irritating to the genital mucosa and difficult to obtain. We report here the effects of common soap and water on HIV as well as white blood cells, which may also play a key role in HIV transmission (1, 4, 11-13).

A commercial bar soap (Ivory: tallow, palm kernel oil, coconut oil, and trace chemicals; Johnson & Johnson) was completely dissolved in warm tap water at several concentrations. The 1-g/200 ml and the 1-g/400 ml solutions resembled standard hand washing conditions according to surveyed laboratory personnel. For these studies, a more dilute solution was used (1 g/1,000 ml) to ascertain possible conditions in the environment.

The direct virucidal action of genital secretions was first measured. HIV type 1 strain SF33 (HIV-1SF33) (10) at 1,275 50% tissue culture infective doses was centrifuged (12,000 x g for 2 h at 4°C) and resuspended in control medium (RPMI 1640 containing 10% fetal calf serum and antibiotics), cervicovaginal lavage fluid (CVL), or a 1:1 mixture of CVL with seminal fluid (SF). HIV centrifugation did not have a notable effect on virus infectivity (data not shown). These virus suspensions were then evaluated for infectivity after exposure to an equal volume of soap and tap water, tap water alone, or control medium for 2 or 6 min. For all virus assays, serial 10-fold dilutions were made with control medium and were inoculated onto 106 phytohemagglutinin-stimulated, Polybrene-treated normal peripheral blood mononuclear cells (PBMCs) separated from blood provided by the Blood Centers of the Pacific (San Francisco, Calif.). The supernatants from triplicate cultures at days 7, 11, and 14 were assayed for viral reverse transcriptase (RT) (2). On day 7, 2.5 x 105 phytohemagglutinin-stimulated PBMCs were added to each RT-negative well.

To determine the effect of soap and water on cell viability, phytohemagglutinin-stimulated PBMCs in either control medium or CVL-SF were exposed to an equal volume of soap and water, tap water, or control medium for 2 or 6 min. The number of viable cells was immediately determined by trypan blue (Sigma) staining. To assess the effect of genital secretions on cell survival, PBMCs were resuspended in control medium, CVL, SF, or CVL-SF. The number of viable cells was then determined at several culture time points.

When HIV was exposed to control medium, CVL alone, SF alone, or CVL-SF, no appreciable effect on viral infectivity was noted until the 6 h time point, when a 10-fold-decreased infectivity of the virus in CVL was observed (data not shown). By 12 h, the CVL had caused a 1,000-fold decrease in virus infectivity. In contrast, HIV in control medium or CVL-SF did not show a 10-fold-decreased infectivity until 12 h after incubation, and at 24 h a 1,000-fold dilution of virus still resulted in a productive infection. Due to the cytotoxic effect of SF on PBMCs, measurements of infectious HIV in this genital fluid were limited to dilute concentrations (>10-3). Under these conditions, HIV infectivity could be found at the 105 dilution until the 1-h time point and at the 104 dilution up to the 12-h time point (data not shown). After an incubation period of 96 h, no infectious virus could be detected in any environment. The mean pHs of the SF and CVL were found to be 7.9 and 4.9, respectively. The pH of the CVL-SF mixture was between 7.4 and 7.9 (mean, 7.75) and did not differ substantially from that of the control medium.

Exposure of HIV to soap and water (1 g/1,000 ml) for 2 or 6 min decreased viral infectivity by more than 1,000-fold (Table 1). When the virus was in a CVL-SF mixture, the virucidal activity of the 1-g/1,000 ml soap and water mixture was completely eliminated. However, with a 1-g/200 ml soap solution, viral infectivity was reduced by more than 30-fold after either 2 or 6 min of exposure (data not shown).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Inactivation of HIV in control medium and genital fluids by soap and water

To evaluate the potential effect of genital fluids on HIV-infected cells, PBMCs were added to the different fluids. Whereas PBMCs cultured in the RPMI 1640 cell culture medium showed vigorous growth, those in the CVL or SF mixtures demonstrated substantially decreased viability (Fig. 1A). Compared to PBMCs in control medium, a >=80% reduction in cell viability occurred by 6 h for PBMCs in CVL, by 12 h for PBMCs in SF, and by 24 h for PBMCs in CVL-SF. When PBMCs resuspended in CVL-SF were exposed to soap and water (1-g/200 ml), there was a 57% reduction (P < 0.05) in the number of viable cells after 2 min and an 87% reduction (P < 0.05) after 6 min compared with numbers of viable PBMCs in control medium (Fig. 1B). PBMCs in CVL-SF mixed with water or a relatively dilute soap and water solution (1-g/1,000 ml) demonstrated no substantial decrease in cell viability.



View larger version (28K):
[in this window]
[in a new window]
  		FIG. 1. Effect of genital fluids and soap and water on PBMCs. (A) PHA-stimulated PBMCs were resuspended in control medium ({diamondsuit}), CVL alone ({blacktriangleup}), SF alone (•), or a 1:1 mixture of CVL and SF ({blacksquare}). The number of viable cells remaining was determined at various time points by trypan blue staining. (B) PBMCs in CVL-SF were exposed to an equal volume of soap and water (1 g/1,000 ml, 1 g/200 ml), tap water alone, or control medium for either 2 or 6 min. Cell viability was determined by trypan blue staining immediately after the end of the exposure period. The percentage of viable cells remaining was calculated by comparing the number of viable cells in each environment with the number of viable cells seen in control medium at the corresponding exposure time.

In addition to the widespread use of soap solutions to clean female barrier contraceptives after their removal from the vaginal canal, several recent studies have indicated that the practice of vaginal cleansing with soap, detergents, or disinfectants is common in the developing world (5, 8). The present study demonstrates that soap and water solutions should be effective in inactivating HIV and HIV-infected cells associated with barrier contraceptives or cells that are present in the vaginal canal. For these experiments, Ivory bar soap was chosen because of its relatively simple ingredients and its accessibility to women internationally. However, soap and water needs to be further evaluated for its effects on the vaginal flora if used as a douche in conjunction with female barrier contraceptives. In addition, in developing countries, access to clean water is imperative for these simple approaches to be effective in preventing HIV transmission.


arrow
ACKNOWLEDGMENTS
 
We thank Alan Landay for providing the CVL specimens.

J. Z. Li is a recipient of the Doris Duke Charitable Foundation Clinical Research Fellowship.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: 513 Parnassus Ave., S1280, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-1270. Phone: (415) 476-4071. Fax: (415) 476-8365. E-mail: jalevy{at}itsa.ucsf.edu. Back


arrow
REFERENCES
 
    1
  1. Belec, L., C. Tevi-Benissan, X. S. Lu, T. Prazuck, and J. Pillot. 1995. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res. Hum. Retrovir. 11:719-729.[Medline]
    2. 2
  2. Hoffman, A. D., B. Banapour, and J. A. Levy. 1985. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326-335.[CrossRef][Medline]
    3. 3
  3. Lavelle, G. C., S. L. Gubbe, J. L. Neveaux, and B. J. Bowden. 1989. Evaluation of an antimicrobial soap formula for virucidal efficacy in vitro against human immunodeficiency virus in a blood-virus mixture. Antimicrob. Agents Chemother. 33:2034-2036.[Abstract/Free Full Text]
    4. 4
  4. Levy, J. A. 1988. The transmission of AIDS: the case of the infected cell. JAMA 259:3037-3038.[Abstract/Free Full Text]
    5. 5
  5. Martin, H. L., B. A. Richardson, P. M. Nyange, L. Lavreys, S. L. Hillier, B. Chohan, K. Mandaliya, J. O. Ndinya-Achola, J. Bwayo, and J. Kreiss. 1999. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180:1863-1868.[CrossRef][Medline]
    6. 6
  6. Martin, L. S., J. S. McDougal, and S. L. Loskoski. 1985. Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus. J. Infect. Dis. 152:400-403.[Medline]
    7. 7
  7. Polsky, B., P. A. Baron, J. W. Gold, J. L. Smith, R. H. Jensen, and D. Armstrong. 1988. In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9. Lancet i:1456.
    8. 8
  8. Reed, B. D., K. Ford, and D. N. Wirawan. 2001. The Bali STD/AIDS study: association between vaginal hygiene practices and STDs among sex workers. Sex. Transm. Infect. 77:46-52.[Abstract/Free Full Text]
    9. 9
  9. Siraprapasiri, T., S. Thanprasertsuk, A. Rodklay, S. Srivanichakorn, P. Sawanpanyalert, and J. Temtanarak. 1991. Risk factors for HIV among prostitutes in Chiangmai, Thailand. AIDS 5:579-582.[Medline]
    10. 10
  10. Tateno, M., and J. A. Levy. 1988. MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV). Virology 167:299-301.[CrossRef][Medline]
    11. 11
  11. Umapathy, E., T. Simbini, T. Chipata, and M. Mbizvo. 2001. Sperm characteristics and accessory sex gland functions in HIV-infected men. Arch. Androl. 46:153-158.[CrossRef][Medline]
    12. 12
  12. Wolff, H., K. Mayer, G. Seage, J. Politch, C. R. Horsburgh, and D. Anderson. 1992. A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men. J. Acquir. Immune Defic. Syndr. 5:65-69.
    13. 13
  13. Xu, C., J. A. Politch, L. Tucker, K. H. Mayer, G. R. Seage III, and D. J. Anderson. 1997. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J. Infect. Dis. 176:941-947.[Medline]

Antimicrobial Agents and Chemotherapy, October 2003, p. 3321-3322, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3321-3322.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J. Z.
Right arrow Articles by Levy, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J. Z.
Right arrow Articles by Levy, J. A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»